Clinical Trial Update: Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing CHS-0214 to Enbrel (etanercept) in chronic plaque psoriasis has completed and results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plauqe Psoriasis

Drugs mentioned

• CHS-0214
• Etanercept (etanercept)

Snippet

Sponsor: Coherus Oncology, Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2019-05-13